Biotech

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 10.10.2023.

Law
Biotechnology
Science
United States
Uncertainty
Pharmaceutical drug

@BioTech Times shared
On Oct 7, 2023
Fake tweet - https://www.investing.com/news/economy/eu-leaders-to-debate-economic-security-amid-global-tensions-3191882
Open
EU leaders resolve to boost economic security amid global tension

EU leaders resolve to boost economic security amid global tension

EU leaders resolve to boost economic security amid global tension

@BioTech Times shared
On Oct 4, 2023
Fake tweet - https://encyclopedia.thefreedictionary.com/Stem+cell
Open
Stem cell

Stem cell

Wikipedia article about Stem cell

@BioTech Times shared
On Oct 5, 2023
Fake tweet - https://ipwatchdog.com/2023/10/04/inventor-profiles-kariko-weissman-earn-nobel-prize-modifying-mrna-paving-way-covid-19-vaccines/id=167858/
Open
Inventor Profiles: Karikó, Weissman Earn Nobel Prize for Modifying mRNA and Paving Way for COVID-19 Vaccines

Inventor Profiles: Karikó, Weissman Earn Nobel Prize for Modifying mRNA and Paving Way for COVID-19 Vaccines

On October 2, the Nobel Assembly at Karolinska Institutet announced that Hungarian-American biochemist Katalin Karikó and American immunologist Drew Weissman were awarded the 2023 Nobel ...

@BioTech Times shared
On Oct 10, 2023
Fake tweet - https://www.bostonglobe.com/2023/10/08/business/family-history-drives-emd-seronos-lori-lebson/
Open
Family history drives EMD Serono’s Lori Lebson

Family history drives EMD Serono’s Lori Lebson

Bold Types is our weekly roundup of the movers and shakers on Boston's business scene.

@BioTech Times shared
On Oct 6, 2023
Fake tweet - https://ipwatchdog.com/2023/10/05/solving-section-101-conundrum-examining-stakeholder-workarounds-vs-legislative-reforms/id=167915/
Open
Solving the Section 101 Conundrum: Examining Stakeholder Workarounds vs. Legislative Reforms

Solving the Section 101 Conundrum: Examining Stakeholder Workarounds vs. Legislative Reforms

Judicial rulings have muddied the waters of patent eligibility, with judges themselves expressing uncertainty.... This haze has driven innovators to tread cautiously, often sidelining ...

@BioTech Times shared
On Oct 4, 2023
Fake tweet - https://www.investing.com/news/stock-market-news/biotech-ipos-see-gradual-resurgence-in-q3-2023-investor-caution-persists-93CH-3189378
Open
Biotech IPOs see gradual resurgence in Q3 2023, investor caution persists

Biotech IPOs see gradual resurgence in Q3 2023, investor caution persists

Biotech IPOs see gradual resurgence in Q3 2023, investor caution persists

@BioTech Times shared
On Oct 5, 2023
Fake tweet - https://www.nlm.nih.gov/news/NCBI-Leadership-update.html
Open
@BioTech Times shared
On Oct 8, 2023
Fake tweet - https://www.forbes.com/sites/goldiechan/2023/10/07/the-branding-potential-of-technology-and-science-with-doctor-melanie-nelson-and-doctor-rebecca-sanchez-sarmiento/
Open
The Branding Potential Of Technology And Science With Doctor Melanie Nelson And Doctor Rebecca Sanchez Sarmiento

The Branding Potential Of Technology And Science With Doctor Melanie Nelson And Doctor Rebecca Sanchez Sarmiento

What is the intersection of technology, science and AI? That's what Dotmatics is currently discovering and working towards.